Drugs.com
A UC San Diego trial of 166 teens found 22% held their loss a year later with mood training, versus 4% with standard counseling. No drugs involved.
Recap by typeshit. Full story at Drugs.com.
Half of people with diabetes for 10 years or more said they were very satisfied on a GLP-1. Gen Z users were the most likely to stop and restart treatment.
64% of current users faced some negative reaction. Men, BIPOC respondents and the newly diagnosed reported it most, while 69% of boomers felt none.
The workflow uses glutathione or sulfatase triggers to target organelles and tumors in mice, and the authors say it takes 92 to 115 days to run.
A University of Pennsylvania mouse study found on-off GLP-1 use left mice 20 per cent heavier than those kept on the drug, and doctors warn human effects are unknown.
A short clip walking through what she eats in a day on Wegovy, for anyone curious how meals look on the drug.
Inc. reports on research into a fat-burning pathway that works differently from Ozempic, which acts on appetite.
Loading…